Brief: Clinica Baviera Buys Optimax

Clinica Baviera SA

27/05/2024 06:24

May 27 (Reuters) - Clinica Baviera SA   CBAV.MC :
    * SAID ON SATURDAY IT SIGNED PURCHASE AND SALE AGREEMENT TO
BUY
BRITISH GROUP OPTIMAX (EYE HOSPITALS GROUP LIMITED AND
SUBSIDIARIES) 
    * AGREEMENT FOR 100% OF OPTIMAX SHARE CAPITAL THROUGH
CASTELLANA
INTERMEDIACION SANITARIA
    * OPTIMAX GROUP'S 2023 TURNOVER WAS AROUND 17 MILLION EUROS
AND
2023 LOSS OF ABOUT 1 MILLION EUROS
    * AGREED AMOUNT FOR ACQUISITION IS 11.7 MILLION EUROS, TO BE
PAID
FROM OWN FUNDS
    * IN ADDITION, VARIABLE ACQUISITION AMOUNT WAS AGREED
SUBJECT TO
EVOLUTION OF GROUP'S EBITDA OVER NEXT 5 YEARS
    * THIS AMOUNT WAS ESTIMATED TO BE BETWEEN 3 MILLION EUROS
AND 11
MILLION EUROS
    * SALE IS SUBJECT TO AUTHORISATION BY FINANCIAL CONDUCT
AUTHORITY
(FCA) DUE TO CHANGE OF CONTROL IN OPTIMAX GROUP
    * DEADLINE FOR FULFILMENT OF CONDITION PRECEDENT WAS SET AT
SIX
MONTHS

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nCNM49ZfZH
 Further company coverage:  CBAV.MC  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))